About Schlesinger St. Louis
Clinical Trials at Schlesinger St. Louis
During the past decade, Schlesinger St. Louis conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Schlesinger St. Louis
According to Clinical.Site data, the most researched conditions in "Schlesinger St. Louis" are
"Smoking" (2 trials), "Tobacco Smoking" (2 trials) and "Tobacco Use" (2 trials). Many other conditions were trialed in "Schlesinger St. Louis" in a lesser frequency.
Clinical Trials Intervention Types at Schlesinger St. Louis
Most popular intervention types in "Schlesinger St. Louis" are "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "40007385" (1 trials), "40007386" (1 trials), "40007387" (1 trials), "40007388" (1 trials) and "P1012818 nicotine pouch" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Schlesinger St. Louis
The vast majority of trials in "Schlesinger St. Louis" are
2 trials for "All" genders.
Clinical Trials Status at Schlesinger St. Louis
Currently, there are NaN active trials in "Schlesinger St. Louis".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Schlesinger St. Louis,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Schlesinger St. Louis, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".